
Each year, RSV sends as many as 58,000 kids under age 5 to U.S. hospitals, but a vaccine in development may dramatically reduce the risk for severe illness. RSV, short for Respiratory Syncytial Virus, typically circulates in fall, winter and spring, causing congestion, runny nose, fever, cough and sore throat. But it can lead to… read on > read on >